Interaction between fatty pancreas disease and genetically predicted glucose-dependent insulinotropic polypeptide on incident type 2 diabetes: evidence from the UK Biobank - Takeaways - MDSpire

Interaction between fatty pancreas disease and genetically predicted glucose-dependent insulinotropic polypeptide on incident type 2 diabetes: evidence from the UK Biobank

  • By

  • Xuechen Wang

  • Yucheng Yang

  • Shumeng Han

  • Zijun Liu

  • Fan Ping

  • Wei Li

  • Lingling Xu

  • Huabing Zhang

  • Yuxiu Li

  • June 8, 2026

  • 0 min

Share

  • 1

    The study investigates the interaction between genetically predicted GIP levels and fatty pancreas disease in type 2 diabetes development.

  • 2

    A significant interaction was found between the E354Q GIPR variant and fatty pancreas, influencing type 2 diabetes risk.

  • 3

    Fatty pancreas disease is linked to a higher risk of type 2 diabetes, especially in individuals without the E354Q variant.

  • 4

    Genetically predicted postprandial GIP levels also increase type 2 diabetes risk in the presence of fatty pancreas disease.

  • 5

    The findings suggest GIP may connect pancreatic fat accumulation to metabolic dysfunction, highlighting its potential role in diabetes.

Original Source(s)

Interaction between fatty pancreas disease and genetically predicted glucose-dependent insulinotropic polypeptide on incident type 2 diabetes: evidence from the UK Biobank

  • by Xuechen Wang, Yucheng Yang, Shumeng Han, Zijun Liu, Fan Ping, Wei Li, Lingling Xu, Huabing Zhang, Yuxiu Li

  • June 8, 2026

Related Content

Staging and Practical Management of Diabetic Retinopathy

Approximately half of patients who have severe NPDR and nearly 75% of patients who have very severe NPDR will progress to PDR within 1 year.

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Experts question diet guidelines' higher protein-intake advice